Preview complete
The prescreener preview is complete. You may now close the preview.
Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening (DRCR AF)
Recruiting
18-79 years
All
Phase
3
650 participants needed
1 Location
Brief description of study
This study seeks to find out whether an oral medication called Fenofibrate can slow or prevent worsening of diabetic retinopathy.
Detailed description of study
This study seeks to find out whether an oral medication called Fenofibrate can slow or prevent worsening of diabetic retinopathy.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Diabetes, Diabetic Retinopathy
-
Age: Between 18 Years - 79 Years
-
Gender: All
Ages 18-79 Diagnosed with Mild-Moderate Diabetic Retinopathy
Updated on
20 Sep 2024.
Study ID: 845026
Pre-Screener
